This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Myriad Genetics Inc (MYGN)

NASDAQ: Services

Company Balance Sheet
Jun 2013 Jun 2012 Jun 2011 Jun 2010
Cash and Equivalents 104.07M 86.35M 52.68M 92.84M
Receivables 97.71M 63.10M 50.85M 47.80M
Inventories 5.01M 11.57M 5.67M 0.00
Other Current Assets 0.00 0.00 0.00 333.00K
Total Current Assets 483.99M 422.49M 418.26M 473.98M
Property, Plant & Equipment, Gross 84.20M 72.53M 64.11M 65.27M
Accumulated Depreciation & Depletion 56.60M 48.30M 41.03M 42.01M
Property, Plant & Equipment, Net 27.60M 24.23M 23.08M 23.26M
Intangibles 13.33M 15.72M 16.72M 0.00
Other Non-Current Assets 193.42M 140.69M 70.86M 96.61M
Total Non-Current Assets 319.83M 268.14M 192.57M 119.87M
Liabilities & Shareholder Equity
Total Assets 803.82M 690.64M 610.83M 593.85M
Accounts Payable 18.13M 10.14M 11.40M 8.87M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 64.51M 44.97M 34.39M 27.47M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 10.01M 9.65M 0.00
Other Non-Current Liabilities 10.72M 0.00 0.00 8.80M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 10.72M 10.01M 9.65M 8.80M
Total Liabilities 75.23M 54.98M 44.04M 36.27M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 728.59M 635.66M 566.79M 557.58M
Common Par 806.00K 826.00K 862.00K 940.00K
Additional Paid In Capital 697.35M 647.68M 604.41M 566.97M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 30.87M -12.68M -38.63M -10.46M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -424.00K -162.00K 151.00K 139.00K
Total Capitalization 728.59M 635.66M 566.79M 557.58M
Total Equity 728.59M 635.66M 566.79M 557.58M
Total Liabilities & Stock Equity 803.82M 690.64M 610.83M 593.85M
Total Common Shares Outstanding 80.58M 82.57M 86.24M 94.05M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 80.95M 84.61M 89.79M 96.34M
Diluted Weighted Shares Outstanding 83.33M 86.46M 91.70M 99.15M
Number of Employees 1325 1169 1057 870
Number of Part-Time Employees 0 0 0 0

MYGN Myriad Genetics Inc

Analysts Ratings for MYGN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 8 8 9 9
Moderate Sell 0 0 0 0
Strong Sell 2 2 2 2

Brokerage Partners

MYGN Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs